19.08.2019
- The US District Court for the District of New Jersey has upheld two of Amgen’s patents for its top-selling drug Enbrel (etanercept) in a ruling against Sandoz, which has been...
10.05.2019
- The US market watchdog Public Citizen has sued the Food and Drug Administration (FDA), demanding that a district court in Washington, DC, require the agency to add “black box”...
17.04.2019
- Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...
05.07.2018
- The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was...
25.04.2017
- Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a...
01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
11.01.2017
- French drugmaker Sanofi and US marketing partner Regeneron have announced they will appeal a ruling by a US federal district court judge that would prevent them from selling their...
